Catalyst Wire Dossier Catalyst Wire Dossier

Transdermal Contraceptive System (Norelgestromin / Ethinyl Estradiol)

Norelgestromin and Ethinyl Estradiol · Janssen-Cilag Farmaceutica Ltda.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Transdermal Contraceptive System (Norelgestromin / Ethinyl Estradiol), covering 2014-05-15 to 2014-05-15. Get the full timeline:

Most recent: Clinical Trial Update: An Open-label Study to Evaluate Contraceptive Efficacy and Safety of the Transdermal Contraceptive System of Norelgestromine and Ethinyl Estradiol [Phase 4]

See pricing